Nigerian drugmaker Fidson selected to manufacture generic influenza antiviral under global licence

Nigerian drugmaker Fidson selected to manufacture generic influenza antiviral under global licence

The selected manufacturers are from Brazil, China, India, Indonesia, Malaysia, Nigeria, Uganda, Ukraine and Vietnam.

The post Nigerian drugmaker Fidson selected to manufacture generic influenza antiviral under global licence appeared first on Premium Times Nigeria.

Originally published by Premium Times.

Read the full article on Premium Times →

2026 Afropolitain Magazine